Lec 6- CIVAS Flashcards
1
Q
CIVAS
Central IntraVenous Additive Service
A
- The central intravenous additive service supplies many medications that require complex aseptic preparation before administration
- MOST COMMON
- Anti-biotics
- Amoxicillin, Teicoplanin
- Analgesics
- Morphine, fentanyl, bupivacaine
- Cytotoxic
- radiodiagnosis
- Anti-biotics
2
Q
Nurses ‘do and don’t’ do bedside compounding of medication
A
- There are many pharmaceutical parameters that must be considered
- Method and route of administration
- Final volume
- Dosage and concentration
- Reconstitution
- Ringers lactate
- Ringers
- Normal saline
- WFI
- Precipitation of active or complexation
- Osmolarity, pH, ionic strength
- ADR’s
- Method and route of administration
3
Q
Infusion fluid types
A
- Why infuse in any of the three different solutions
- 5% GLUCOSE
- 0.9% NaCl
- Compound Sodium Lactate
- Why not just use water for injection (WFI)
- Not osmotically equivalent to blood= pain/phlebitis
4
Q
Question
What is the osmolarity (mOsmol) of a 5% glucose solution
MW Glu = 180.2
A
5
Q
Make sure you know
A
- CIVAS
- Some fo the most common drugs that might be seen
- BNF Key chapters
- Sec 9
- Appendix A6
- Calculations from real life data
6
Q
Why infuse in any of the 3 different solutions
A
- 5% Glu = 278 mOsmol
- 0.9% NaCl = 308 mOsmol
- Ringers Lactate = 278 mOsmol (BE CAREFUL)
7
Q
Volume
A
- A pharmacist needs to supply a suitable volume for both the drug and infusion pump (rate)
8
Q
Volume question
A
9
Q
Ionic strength
A
- The reaction rate is often influenced by the ionic strength of the diluent
- Za, Zb numerical charges (2+, -1 etc) of reacting species u is ionic strength, Ko is reaction rate constant, B constant for ionic diameter
- Ampicillin at a constant pH has its rate of hydrolysis altered by the concentration of phosphate or citrate used in the buffer
*
10
Q
pH
A
- Not in Teicoplanins case but in several cases drug hydrolysis is controlled by pH
- Amphotericin in D5W must be >4.2 to be stable
- Erythromycin can diluted in D5W or in normal salign but is more stable in 0.9% NaCl
11
Q
Pharmaceutics
Formulation development matters
A
- Viable/ Non-viable contamination
- Additive ranges/ compatibility
- Osmolarity of the solution
- Rate of infusion
- Volume of infusion
- Location of infusion
- Ionisation
- pH
- Your safety (cytotoxic)